TRIM67: A Potential Drug Target and Biomarker (G440730)

Target Name: TRIM67

NCBI ID: G440730

TRIM67

TRIM67: A Potential Drug Target and Biomarker

TRIM67, short for tripartite motif containing 67, is a non-coding RNA molecule that has been identified as a potential drug target and biomarker. Its unique structure and novel function have piqued the interest of researchers and may hold the key to new therapeutic approaches for a range of diseases.

The TRIM67 molecule was first identified in the human genome using transcript variant 2 technology. It is a small RNA molecule that contains only 22 amino acid residues and is found in various tissues and cell types. The TRIM67 molecule has a characteristic tripartite motif, which consists of three distinct regions: an N-terminal region, a middle region, and an A-terminal region.

The N-terminal region of TRIM67 contains a unique feature that is not found in any other RNA molecule. It contains a specific RNA structure called a stem-loop, which is a type of secondary structure that is composed of a central stem and two loops that are connected to the stem. The stem-loop region of TRIM67 is made up of four amino acids and is located at the base of the third amino acid residue.

The middle region of TRIM67 is characterized by a series of alternating between Asp and Asn amino acids. This region is known as the core region and is the primary region of TRIM67 that has been shown to have various functions. The Asp and Asn amino acids in the core region interacts with each other and with the N-terminal region, which may contribute to the unique structure and function of TRIM67.

The A-terminal region of TRIM67 is also characterized by a series of alternating between Asp and Asn amino acids. This region is known as the terminal region and is located at the tip of the TRIM67 molecule. The Asp and Asn amino acids in the terminal region interact with each other, as well as with the middle region, and may contribute to the various functions of TRIM67.

The unique structure and function of TRIM67 have led to its potential as a drug target and biomarker. One of the main reasons for this is the presence of the stem-loop region in the N-terminal region of TRIM67. This region has been shown to have various functions in various RNA molecules, including the regulation of gene expression and the control of post-transcriptional modification. By targeting TRIM67 with small molecules or antibodies, researchers may be able to disrupt its function and study its role in disease.

Another potential function of TRIM67 is its role as a biomarker. Its unique structure and function make it an attractive candidate for use as a diagnostic or diagnostic biomarker for a range of diseases. For example, TRIM67 has been shown to be expressed in various tissues and conditions, including cancer, neurodegenerative diseases, and respiratory diseases. By using TRIM67 as a biomarker, researchers may be able to diagnose or monitor the progression of these conditions and develop new treatments.

In conclusion, TRIM67 is a non-coding RNA molecule that has unique structure and function. Its characteristic tripartite motif and presence of the stem-loop region in the N-terminal region have led to its potential as a drug target and biomarker. Further research is needed to fully understand its role in disease and develop new therapeutic approaches.

Protein Name: Tripartite Motif Containing 67

The "TRIM67 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TRIM67 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets